About Us (Company History)


Company History


2017
Company launches on the Nasdaq First North stock exchange
2017
New Head Quarters office opened in Stockholm Sweden
2017
New AnaConDa-S launched in Europe
2017
KFDA approve AnaConDa in South Korea
2017
Christer Ahlberg appointed as new CEO
2016
Decision made to invest in a clinical study in Germany leading to Market Authorization of sedation in the ICU in Europe
2016
Over 200,000 devices used since launch
2015
Study finds that one year mortality is significantly lower in isoflurane vs. IV sedated patients
2014
AnaConDa now being used in Canada, Australia most of Europe
2013
New R&D office opened in Kildare Ireland
2012
New Office Sales office opened in Madrid Spain
2008
Study shows that short-term sevoflurane sedation using AnaConDa after cardiothoracic surgery significantly reduces ventilation time and hospital stay
2007
Sedana establishes test market in Germany
2005
Sedana Medical office opens in Germany
2005
Sedana Medical Founded In Uppsala Sweden
1999
AnaConDa first used in Sweden in the mid 90's and tested in a clinical setting for the first time